Weekly Journal Scan: improved renal outcomes by semaglutide in patients with chronic kidney disease and type 2 diabetes in FLOW trial.
Eur Heart J
; 45(38): 3910-3911, 2024 Oct 07.
Article
in En
| MEDLINE
| ID: mdl-38985093
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 2
/
Glucagon-Like Peptides
/
Renal Insufficiency, Chronic
/
Hypoglycemic Agents
Limits:
Humans
Language:
En
Journal:
Eur Heart J
Year:
2024
Document type:
Article
Affiliation country:
Italy
Country of publication:
United kingdom